For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
A hauora Māori nail-biter as new bill awaited
+Opinion
In print
A hauora Māori nail-biter as new bill awaited
Thursday 30 September 2021, 10:46 AM

The Waitangi Tribunal met at Pipitea Marae, among others, as part of its stage-one hearings in the Health Services and Outcomes Kaupapa Inquiry
Gabrielle Baker says much can be learned from the Crown’s history of trying (and failing) to set up Māori health entities
By the 1930s, Māori health effectively became “mainstreamed” and absorbed into the Department of Health
Any day now, we can expect legislation to
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.